Spears Abacus Advisors LLC Danaher Corp Transaction History

Spears Abacus Advisors LLC

  • $4.73 Billion
  • Q3 2024

A detailed history of Spears Abacus Advisors LLC transactions in Danaher Corp stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 234,485 shares of DHR stock, worth $53.6 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares
234,485
Previous 230,059 1.92%
Holding current value
$53.6 Million
Previous $57.5 Million 13.4%
% of portfolio
1.38%
Previous 1.24%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$239.25 - $280.76 $1.06 Million - $1.24 Million
4,426 Added 1.92%
234,485 $65.2 Million
Q2 2024

Aug 12, 2024
SELL
$235.51 - $267.98 $458,537 - $521,757
-1,947 Reduced 0.84%
230,059 $57.5 Million
Q1 2024

May 10, 2024
BUY
$224.58 - $256.19 $21.2 Million - $24.2 Million
94,329 Added 68.51%
232,006 $57.9 Million
Q3 2023

Nov 21, 2023
BUY
$233.08 - $265.59 $452,874 - $516,041
1,943 Added 1.43%
137,677 $34.2 Million
Q2 2023

Aug 14, 2023
BUY
$224.99 - $256.14 $285,962 - $325,553
1,271 Added 0.95%
135,734 $32.6 Million
Q1 2023

May 15, 2023
SELL
$239.75 - $277.0 $65,931 - $76,175
-275 Reduced 0.2%
134,463 $33.9 Million
Q4 2022

Feb 13, 2023
SELL
$241.42 - $282.29 $1.89 Million - $2.21 Million
-7,843 Reduced 5.5%
134,738 $35.8 Million
Q3 2022

Nov 14, 2022
SELL
$247.06 - $1507.4 $1.72 Million - $10.5 Million
-6,962 Reduced 4.66%
142,581 $36.8 Million
Q2 2022

Aug 08, 2022
BUY
$237.11 - $299.66 $349,974 - $442,298
1,476 Added 1.0%
149,543 $37.9 Million
Q1 2022

May 13, 2022
SELL
$257.27 - $315.76 $80,525 - $98,832
-313 Reduced 0.21%
148,067 $43.4 Million
Q4 2021

Feb 14, 2022
SELL
$292.08 - $329.01 $107,193 - $120,746
-367 Reduced 0.25%
148,380 $48.8 Million
Q3 2021

Nov 15, 2021
SELL
$272.21 - $332.43 $75,674 - $92,415
-278 Reduced 0.19%
148,747 $45.3 Million
Q2 2021

Aug 09, 2021
SELL
$225.08 - $271.69 $106,237 - $128,237
-472 Reduced 0.32%
149,025 $40 Million
Q1 2021

May 14, 2021
SELL
$212.38 - $245.9 $9.43 Million - $10.9 Million
-44,416 Reduced 22.91%
149,497 $33.6 Million
Q4 2020

Feb 12, 2021
SELL
$212.5 - $245.46 $5.52 Million - $6.38 Million
-25,974 Reduced 11.81%
193,913 $43.1 Million
Q3 2020

Nov 16, 2020
SELL
$177.16 - $215.33 $10.9 Million - $13.3 Million
-61,808 Reduced 21.94%
219,887 $47.3 Million
Q2 2020

Aug 12, 2020
SELL
$128.7 - $176.83 $373,873 - $513,691
-2,905 Reduced 1.02%
281,695 $49.8 Million
Q1 2020

May 15, 2020
SELL
$121.39 - $169.05 $3.74 Million - $5.21 Million
-30,799 Reduced 9.77%
284,600 $39.4 Million
Q4 2019

Feb 14, 2020
SELL
$133.47 - $153.48 $212,617 - $244,493
-1,593 Reduced 0.5%
315,399 $48.4 Million
Q3 2019

Nov 14, 2019
SELL
$135.4 - $146.47 $374,381 - $404,989
-2,765 Reduced 0.86%
316,992 $45.8 Million
Q2 2019

Aug 09, 2019
SELL
$124.88 - $143.73 $60,441 - $69,565
-484 Reduced 0.15%
319,757 $45.7 Million
Q1 2019

May 14, 2019
BUY
$97.62 - $132.29 $17,669 - $23,944
181 Added 0.06%
320,241 $42.3 Million
Q4 2018

Feb 13, 2019
SELL
$94.85 - $109.54 $499,005 - $576,289
-5,261 Reduced 1.62%
320,060 $33 Million
Q3 2018

Nov 13, 2018
SELL
$98.13 - $108.9 $317,941 - $352,836
-3,240 Reduced 0.99%
325,321 $35.3 Million
Q2 2018

Aug 10, 2018
SELL
$96.1 - $103.24 $155,970 - $167,558
-1,623 Reduced 0.49%
328,561 $32.4 Million
Q1 2018

May 15, 2018
SELL
$92.16 - $103.8 $347,627 - $391,533
-3,772 Reduced 1.13%
330,184 $32.3 Million
Q4 2017

Feb 14, 2018
SELL
$85.26 - $94.62 $153,468 - $170,316
-1,800 Reduced 0.54%
333,956 $31 Million
Q3 2017

Nov 13, 2017
BUY
$79.29 - $88.45 $256,503 - $286,135
3,235 Added 0.97%
335,756 $28.8 Million
Q2 2017

Aug 11, 2017
BUY
N/A
332,521
332,521 $28.1 Million

Others Institutions Holding DHR

# of Institutions
2,511
Shares Held
539M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $166B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Spears Abacus Advisors LLC Portfolio

Follow Spears Abacus Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spears Abacus Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email